Dergiler / European Journal of Rheumatology / 2018 / Cilt: 5 - Sayı: 2

Muscle weakness as a presenting symptom in ANCA-associated vasculitis

Sayfa
139–141
Yayın Tarihi
2022-10-18
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The literature review, including three similar cases, suggested that pa-tients with ANCA-associated muscle vasculitis likely had myalgia, normal levels of creatine kinase,pulmonary fibrosis, rheumatoid factor, and muscle edema on MRI.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Muscle weakness is rarely a presenting symptom of anti-neutrophil cytoplasmic antibody (ANCA)-as-sociated vasculitis (AAV), although the disease frequently involves the lungs, skin, neurons, and kid-neys.
📊
Temel Bulgular & Veri:Here we describe a case of AAV presenting with muscle weakness in which only muscle biopsycould confirm the diagnosis.
💡
Sonuç & Katkı:The literature review, including three similar cases, suggested that pa-tients with ANCA-associated muscle vasculitis likely had myalgia, normal levels of creatine kinase,pulmonary fibrosis, rheumatoid factor, and muscle edema on MRI.
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Muscle weakness is rarely a presenting symptom of anti-neutrophil cytoplasmic antibody (ANCA)-as-sociated vasculitis (AAV), although the disease frequently involves the lungs, skin, neurons, and kid-neys. Here we describe a case of AAV presenting with muscle weakness in which only muscle biopsycould confirm the diagnosis. The literature review, including three similar cases, suggested that pa-tients with ANCA-associated muscle vasculitis likely had myalgia, normal levels of creatine kinase,pulmonary fibrosis, rheumatoid factor, and muscle edema on MRI.

🔖

Bu Makaleye Atıf Yap

OİWA, H., KURASHIGE, T. (2022). Muscle weakness as a presenting symptom in ANCA-associated vasculitis. European Journal of Rheumatology, Cilt: 5 - Sayı: 2, 139–141. https://ajindex.com/articles/511624

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (1)

  1. Pagnoux C. Updates in ANCA-associated vasculi- tis. Eur J Rheumatol 2016; 3: 122-133. [CrossRef] Watts R, Lane S, Hanslik T, Hauser T, Hellmich B, Koldingsnes W, et al. Development and valida- tion of a consensus methodology for the classi- fication of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 2007; 66: 222-7. [CrossRef] Birnbaum J, Danoff S, Askin FB, Stone JH. Microscopic polyangiitis presenting as a «pulmonary-muscle» syndrome: is subclini- cal alveolar hemorrhage the mechanism of pulmonary fibrosis? Arthritis Rheum 2007; 56: 2065-71. [CrossRef ] Kim MY, Bae SY, Lee M, Chung H, Lee J, Ahn JK, et al. A case of ANCA-associated vasculitis pre- senting with calf claudication. Rheumatol Int 2012; 32: 2909-12. [CrossRef ] Hervier B, Durant C, Masseau A, Ponge T, Hami- dou M, Mussini JM. Use of muscle biopsies for diagnosis of systemic vasculitides. J Rheumatol 2011; 38: 470-4. [CrossRef ] Tzelepis GE, Kokosi M, Tzioufas A, Toya SP, Boki KA, Zormpala A, et al. Prevalence and outcome of pulmonary fibrosis in microscopic polyangii- tis. Eur Respir J 2010; 36: 116-21. [CrossRef ] Hervier B, Pagnoux C, Agard C, Haroche J, Amou- ra Z, Guillevin L, et al. Pulmonary fibrosis associ- ated with ANCA-positive vasculitides. Retrospec- tive study of 12 cases and review of the literature. Ann Rheum Dis 2009; 68: 404-7. [CrossRef] Ando M, Miyazaki E, Ishii T, Mukai Y, Yamasue M, Fujisaki H, et al. Incidence of myeloperoxidase anti-neutrophil cytoplasmic antibody positivity and microscopic polyangitis in the course of id- iopathic pulmonary fibrosis. Respir Med 2013; 107: 608-15. [CrossRef ] Kagiyama N, Takayanagi N, Kanauchi T, Ishiguro T, Yanagisawa T, Sugita Y. Antineutrophil cyto- plasmic antibody-positive conversion and mi- croscopic polyangiitis development in patients with idiopathic pulmonary fibrosis. BMJ Open Respir Res 2015; 2: e000058. [CrossRef ]